- Home
- MYNZ vs ADXN Comparison
MYNZ vs ADXN Comparison
Compare MYNZ & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYNZ
- ADXN
- Stock Information
- Founded
- MYNZ 2021
- ADXN 2002
- Country
- MYNZ Germany
- ADXN Switzerland
- Employees
- MYNZ N/A
- ADXN N/A
- Industry
- MYNZ Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- MYNZ Health Care
- ADXN Health Care
- Exchange
- MYNZ Nasdaq
- ADXN Nasdaq
- Market Cap
- MYNZ 8.0M
- ADXN 8.1M
- IPO Year
- MYNZ 2021
- ADXN N/A
- Fundamental
- Price
- MYNZ $2.08
- ADXN $10.23
- Analyst Decision
- MYNZ Buy
- ADXN Strong Buy
- Analyst Count
- MYNZ 2
- ADXN 1
- Target Price
- MYNZ $14.00
- ADXN $30.00
- AVG Volume (30 Days)
- MYNZ 93.5K
- ADXN 3.8K
- Earning Date
- MYNZ 06-17-2025
- ADXN 06-17-2025
- Dividend Yield
- MYNZ N/A
- ADXN N/A
- EPS Growth
- MYNZ N/A
- ADXN N/A
- EPS
- MYNZ N/A
- ADXN 0.08
- Revenue
- MYNZ $893,991.00
- ADXN $452,495.00
- Revenue This Year
- MYNZ $26.06
- ADXN $86.57
- Revenue Next Year
- MYNZ $4.97
- ADXN N/A
- P/E Ratio
- MYNZ N/A
- ADXN $0.93
- Revenue Growth
- MYNZ N/A
- ADXN N/A
- 52 Week Low
- MYNZ $1.92
- ADXN $6.51
- 52 Week High
- MYNZ $34.00
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- MYNZ 38.07
- ADXN 73.57
- Support Level
- MYNZ $1.93
- ADXN $8.08
- Resistance Level
- MYNZ $2.10
- ADXN $8.20
- Average True Range (ATR)
- MYNZ 0.16
- ADXN 0.23
- MACD
- MYNZ 0.04
- ADXN 0.11
- Stochastic Oscillator
- MYNZ 30.39
- ADXN 71.04
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.